189 related articles for article (PubMed ID: 6192089)
21. BCG immunotherapy of metastatic adenocarcinoma of the kidney.
Eidinger D; Morales A
Natl Cancer Inst Monogr; 1978 Dec; (49):339-41. PubMed ID: 748790
[No Abstract] [Full Text] [Related]
22. [Treatment of advanced primary lung cancer, particularly immunotherapy with BCG-CWS (author's transl)].
Ohta M; Iida A; Ueda H; Yasumoto K; Manabe H
Kyobu Geka; 1977 Jul; 30(7):581-5. PubMed ID: 904107
[No Abstract] [Full Text] [Related]
23. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
24. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
25. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
Grant SC; Kris MG; Houghton AN; Chapman PB
Clin Cancer Res; 1999 Jun; 5(6):1319-23. PubMed ID: 10389914
[TBL] [Abstract][Full Text] [Related]
26. [Immunotherapy of brain tumors].
Takakura K; Watanabe T
No Shinkei Geka; 1982 Dec; 10(12):1245-54. PubMed ID: 6188989
[No Abstract] [Full Text] [Related]
27. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy].
Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H
Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535
[No Abstract] [Full Text] [Related]
28. [BCG immunotherapy in lung neoplasms following surgery--evaluation by randomized clinical study].
Miyasawa N; Suemasu K; Yoneyama T; Naruke T; Ogata T
Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):447-9. PubMed ID: 381534
[No Abstract] [Full Text] [Related]
29. Small-cell lung cancer.
Simon G; Ginsberg RJ; Ruckdeschel JC
Chest Surg Clin N Am; 2001 Feb; 11(1):165-88, ix. PubMed ID: 11253596
[TBL] [Abstract][Full Text] [Related]
30. Small cell cancer of the lung.
Carney DN; Minna JD
Clin Chest Med; 1982 May; 3(2):389-98. PubMed ID: 6284438
[No Abstract] [Full Text] [Related]
31. Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.
Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
Cancer Treat Rev; 1979 Sep; 6(3):177-90. PubMed ID: 394836
[No Abstract] [Full Text] [Related]
32. [Immunotherapy of lung cancer using BCG cell-wall skeleton].
Yasumoto K
Kekkaku; 1977 Oct; 52(10):530-1. PubMed ID: 340747
[No Abstract] [Full Text] [Related]
33. Immunotherapy of lung cancer.
Fishbein GE
Semin Oncol; 1993 Aug; 20(4):351-8. PubMed ID: 8342064
[TBL] [Abstract][Full Text] [Related]
34. Developments in immunotherapy.
Krakowka S
Mod Vet Pract; 1981 Jun; 62(6):447-51. PubMed ID: 6166843
[TBL] [Abstract][Full Text] [Related]
35. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
36. Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
Banna P; Murabito R; Saggio A; Cordopatri F; Riggi M; Campo ME; Cinà C; Latteri S
Ital J Surg Sci; 1983; 13(2):133-7. PubMed ID: 6195126
[TBL] [Abstract][Full Text] [Related]
37. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
[TBL] [Abstract][Full Text] [Related]
38. Small-cell bronchogenic carcinoma; advances in treatment.
Bergevin PR
N Y State J Med; 1980 Nov; 80(12):1847-50. PubMed ID: 6262689
[No Abstract] [Full Text] [Related]
39. HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.
Wang W; Nishioka Y; Ozaki S; Jalili A; Abe S; Kakiuchi S; Kishuku M; Minakuchi K; Matsumoto T; Sone S
Cancer Immunol Immunother; 2009 Jun; 58(6):967-76. PubMed ID: 18979097
[TBL] [Abstract][Full Text] [Related]
40. Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Krug LM; Grant SC; Miller VA; Ng KK; Kris MG
Semin Oncol; 1999 Oct; 26(5 Suppl 15):55-61. PubMed ID: 10566613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
